Related Experiment Videos
Extracellular matrix dynamics associated with tissue-engineered intravascular sclerotherapy.
Adam M Vogel1, C Jason Smithers, Harry P Kozakewich
1Department of Surgery, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA.
Journal of Pediatric Surgery
|March 29, 2006
Summary
Tissue engineering with fibroblasts enhances intravascular sclerotherapy by increasing collagen and glycosaminoglycan deposition. This approach may improve outcomes for vascular malformations.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Vascular Surgery
Background:
- The extracellular matrix dynamics following intravascular sclerotherapy using fibroblast-based engineered constructs remain unclear.
- Understanding these dynamics is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate the extracellular matrix changes after intravascular sclerotherapy with a tissue-engineered construct.
- To evaluate the impact of fibroblast-based constructs on vascular repair and remodeling.
Main Methods:
- Ethanol sclerotherapy was performed on rabbit jugular vein segments.
- Experimental groups received either an acellular collagen hydrogel or a fibroblast-based tissue-engineered construct.
- Tissue analysis for collagen, glycosaminoglycan (GAG), matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs) was conducted at multiple time points.
Main Results:
- Fibroblast-treated animals showed significantly higher collagen content.
- Elevated collagen and GAG deposition were observed between weeks 1 and 4, decreasing thereafter.
- MMP and TIMP levels decreased over time across all groups, with no significant intergroup differences.
Conclusions:
- Tissue engineering enhances intravascular sclerotherapy through increased local collagen and GAG deposition.
- MMPs and TIMPs may influence recanalization following experimental sclerotherapy.
- Tissue engineering presents a promising adjunct for treating vascular malformations.